Ann Zeuner

Dr. Ann Zeuner


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2006 in Cell Death & Differentiation
Verified
Journal Article
Closed access
AEAdriana Eramo
Adriana Eramo
LRLucia Ricci-Vitiani
Lucia Ricci-Vitiani
AZAnn Zeuner
Ann Zeuner
RPRoberto Pallini
Roberto Pallini
FLF Lotti
F Lotti
RMRuggero De Maria
Ruggero De Maria

1 December 2014 in Cell Stem Cell
Verified
Journal Article
Closed access
AZAnn Zeuner
Ann Zeuner
MTMatilde Todaro
Matilde Todaro
GSGiorgio Stassi
Giorgio Stassi
RMRuggero De Maria
Ruggero De Maria

12 September 1997 in Science
Verified
Journal Article
Closed access
RMRuggero De Maria
Ruggero De Maria
LLLuisa Lenti
Luisa Lenti
FMFLORENCE MALISAN
FLORENCE MALISAN
FDFederica D'Agostino
Federica D'Agostino
BTBarbara Tomassini
Barbara Tomassini
RTRoberto Testi
Roberto Testi
Gangliosides participate in development and tissue differentiation. Cross-linking of the apoptosis-inducing CD95 protein (also called Fas or APO-1) in lymphoid and myeloid tumor cells triggered GD3 ganglioside synthesis and transient accumulation. CD95-induced GD3 accumulation depended on integral receptor “death domains” and on activation of a family of cysteine proteases called caspases. Cell-permeating ceramides, which are potent inducers of apoptosis, also triggered GD3 synthesis. GD3 disrupted mitochondrial transmembrane potential (ΔΨ m ), and induced apoptosis, in a caspase-independent fashion. Transient overexpression of the GD3 synthase gene directly triggered apoptosis. Pharmacological inhibition of GD3 synthesis and exposure to GD3 synthase antisense oligodeoxynucleotides prevented CD95-induced apoptosis. Thus, GD3 ganglioside mediates the propagation of CD95-generated apoptotic signals in hematopoietic cells.

1 September 1999 in Nature
Verified
Journal Article
Closed access
RMRuggero De Maria
Ruggero De Maria
AZAnn Zeuner
Ann Zeuner
AEAdriana Eramo
Adriana Eramo
CDCristina Domenichelli
Cristina Domenichelli
DBDesiree Bonci
Desiree Bonci
CPCesare Peschle
Cesare Peschle

10 December 2006 in Nature
Verified
Journal Article
Closed access
PDF file
JRJean-Antoine Ribeil
Jean-Antoine Ribeil
YZYael Zermati
Yael Zermati
JVJulie Vandekerckhove
Julie Vandekerckhove
SCSeverine Cathelin
Severine Cathelin
JKJoelle Kersual
Joelle Kersual
OHOlivier Hermine
Olivier Hermine

1 October 1998 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
NPNagendra K A Prasad
Nagendra K A Prasad
GPGiuliana Papoff
Giuliana Papoff
AZAnn Zeuner
Ann Zeuner
EBEmmanuelle Bonnin
Emmanuelle Bonnin
MKMichel D. Kazatchkine
Michel D. Kazatchkine
SKSrini V. Kaveri
Srini V. Kaveri
Therapeutic preparations of normal human IgG for i.v. use (IVIg) exhibit a broad spectrum of immunoregulatory activities in vitro and in vivo. IVIg has been shown to inhibit the proliferation of activated B and T lymphocytes and of several autonomously growing cell lines. In this study, we demonstrate that IVIg induces apoptosis in leukemic cells of lymphocyte and monocyte lineage and in CD40-activated normal tonsillar B cells, involving, at least in part, Fas (CD95/APO-1) and activation of caspases. IVIg-induced apoptosis was higher in Fas-sensitive HuT78 cells than in Fas-resistant HuT78.B1 mutant cells, and soluble Fas inhibited IVIg-induced apoptosis. IVIg immunoprecipitated Fas from Fas-expressing transfectants and recognized purified Fas/glutathione-S-transferase fusion proteins upon immunoblotting. Affinity-purified anti-Fas Abs from IVIg induced apoptosis of CEM T cells at a 120-fold lower concentration than unfractionated IVIg. Inhibitors of cysteine proteases of the caspase family, caspase 1 (IL-1β-converting enzyme) and caspase 3 (Yama/CPP32b), partially inhibited IVIg-induced apoptosis of CEM cells. Furthermore, cleavage of poly(A)DP-ribose polymerase into an 85-kDa signature death fragment was observed in CEM cells following IVIg treatment. Thus, normal IgG induces apoptosis in lymphocytes and monocytes. Our results provide evidence for a role of Fas, bring new insights into the mechanisms of action of IVIg in autoimmune diseases, and suggest a role of normal Ig in controlling cell death and proliferation.